What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to officially report Merck's financial results for the first quarter of 2013. It signals that the company has released its earnings and provides access to the relevant documents.

Where can I find the detailed Q1 2013 financial results?

The detailed Q1 2013 financial results are not directly included in the 8-K form itself. Instead, they are incorporated by reference into a press release (Exhibit 99.1) and supplemental information (Exhibit 99.2) that are attached to this filing. Investors should review these exhibits for comprehensive financial data.

Is this filing considered a legal 'filing' for Section 18 liability?

No, the information furnished under Item 2.02 in this 8-K, including the incorporated exhibits, is specifically stated as not being deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934. This means it does not carry the same legal liabilities as formally filed documents under that section, although it is still important for investor awareness.

What kind of information is likely included in the supplemental information (Exhibit 99.2)?

The supplemental information (Exhibit 99.2) likely contains additional financial details, metrics, or breakdowns that were not part of the main press release (Exhibit 99.1). This could include more granular segment reporting, specific product sales data, guidance updates, or other operational metrics that management believes are important for investors to understand the company's performance.

MRK 8-K: Earnings & Results

Summary

Merck & Co., Inc. (MRK) filed an 8-K on May 1, 2013, to report its first-quarter 2013 financial results. This filing primarily incorporates by reference a press release and supplemental financial information detailing the company's performance during the period. Investors should refer to these attached documents for specific financial figures, operational highlights, and management's commentary on the quarter's outcomes. The key takeaway for investors is that this 8-K serves as a notification of the release of Q1 2013 earnings. While the 8-K itself does not contain the detailed financial statements, it directs stakeholders to the accompanying press release (Exhibit 99.1) and supplemental data (Exhibit 99.2) for a comprehensive understanding of Merck's financial condition and results of operations for the period ending March 31, 2013. These exhibits would contain crucial information regarding revenue, profitability, and any significant business developments.

Key Highlights

18-K filing on May 1, 2013, relates to Merck's Q1 2013 earnings report.
2The filing incorporates by reference a press release detailing Q1 2013 financial results.
3Supplemental financial information not included in the press release is also incorporated.
4This report serves as official notification of the company's quarterly financial performance.
5Investors are directed to Exhibits 99.1 and 99.2 for detailed financial information.
6The information is furnished under Item 2.02 (Results of Operations and Financial Condition).

Merck & Co., Inc. 8-K Report, Financial Results (May 1, 2013)

Summary

Key Highlights

Frequently Asked Questions